|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 76.23 EUR | -0.33% |
|
+0.55% | -7.85% |
| 07-10 | Sanofi Receives Fda Approval for Subcutaneous Sarclisa Escena Administered Via On-Body Injector | CI |
| 07-10 | Sanofi Wins US FDA Approval for Subcutaneous Sarclisa Escena in Multiple Myeloma | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SANOFI | Other Pharmaceuticals | -0.33% | +0.55% | -7.85% | -9.42% | -12.60% | 105B |  |  | |
- Stock Market
- Stocks
- SAN Stock
- Charts Sanofi
- Comparison Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition